Furosemide use and survival in patients with esophageal or gastric cancer: a population-based cohort study

BACKGROUND: Pre-clinical studies have shown that furosemide slows cancer cell growth by acting on the Na-K-2Cl transporter, particularly for gastric cancer cells. However, epidemiological studies have not investigated furosemide use and mortality in gastroesophageal cancer patients. Consequently, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Peipei, McMenamin, Úna C., Spence, Andrew D., Johnston, Brian T., Coleman, Helen G., Cardwell, Chris R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819347/
https://www.ncbi.nlm.nih.gov/pubmed/31664951
http://dx.doi.org/10.1186/s12885-019-6242-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819347/
https://www.ncbi.nlm.nih.gov/pubmed/31664951
http://dx.doi.org/10.1186/s12885-019-6242-8

Ejemplares similares